Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)

BACKGROUND: This was an indirect comparison of the effectiveness of intravitreal aflibercept (IVT-AFL) 2 mg every 8 weeks after 5 initial monthly doses (or if different periods, after an initial monthly dosing period) (2q8) and other diabetic macular edema (DME) therapies at doses licensed outside t...

Descripción completa

Detalles Bibliográficos
Autores principales: Korobelnik, Jean-Francois, Kleijnen, Jos, Lang, Shona H, Birnie, Richard, Leadley, Regina M, Misso, Kate, Worthy, Gill, Muston, Dominic, Do, Diana V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467379/
https://www.ncbi.nlm.nih.gov/pubmed/25975823
http://dx.doi.org/10.1186/s12886-015-0035-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467379/
https://www.ncbi.nlm.nih.gov/pubmed/25975823
http://dx.doi.org/10.1186/s12886-015-0035-x

Ejemplares similares